Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2023-008422 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Bingting Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We have read with great interest the recent publication titled ‘Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors’ by Magahis et al .[1][1] The study presents intriguing findings on the association
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
- Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands g.fuhler@erasmusmc.nl.
ORCID-Profile: Bingting Yu
Zitieren
APA
Yu, B., Peppelenbosch, M., & Fuhler, G. (2024). Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008422
Vancouver
Yu B, Peppelenbosch M, Fuhler G. Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-008422
BibTeX
@article{Yu2024,
author = {Yu, Bingting and Peppelenbosch, Maikel and Fuhler, Gwenny},
title = {Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2023-008422}
}
EUVIMED